Analyst Gary Prestopino of Barrington reiterated a Buy rating on Stoneridge, reducing the price target to $14.50.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Gary Prestopino has given his Buy rating due to a combination of factors that highlight Stoneridge’s potential for growth and resilience in challenging market conditions. The company’s Q3/25 financial performance showed adjusted EBITDA figures that exceeded expectations when excluding non-operating foreign exchange expenses. Despite facing macroeconomic pressures that affected sales, Stoneridge managed to improve its operating margin and reduce quality-related costs significantly.
Moreover, Stoneridge’s strategic initiatives, such as the expansion of its MirrorEye program and new business wins in Control Devices, underscore its capacity to capture market opportunities. The substantial increase in MirrorEye sales, particularly in Europe and North America, and the securing of new program awards, including a significant OEM program, reflect the company’s strong positioning in the market. These developments, alongside the company’s robust backlog and successful cost management, contribute to the positive outlook that supports the Buy rating.
SRI’s price has also changed moderately for the past six months – from $5.150 to $5.810, which is a 12.82% increase.

